You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 6, JUNE 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (48)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Natural Course of Multiple Endocrine Neoplasia Type iib

A Study of 18 Cases

Hans F. A. Vasen, MD; Machteld van der Feltz, MD; Friedhelm Raue, MD; Arie Nieuwenhuyzen Kruseman, MD; Hans P. F. Koppeschaar, MD; Gerlach Pieters, MD; Fritz J. Seif, MD; Werner F. Blum, MD; Cees J. M. Lips, MD

Arch Intern Med. 1992;152(6):1250-1252.


Abstract

Background.—
Multiple endocrine neoplasia (MEN) type IIb is an autosomal dominantly inherited disorder associated with medullary thyroid cancer, pheochromocytoma, and a characteristic phenotype. The present study was performed to investigate the natural course of the syndrome and to describe its expression.

Methods.—
The medical records of 18 patients with MEN IIb, seven male and 11 female, were reviewed.

Results.—
The mean age at diagnosis of MEN IIb was 18 years (range, 8 to 41 years). All 18 patients had medullary thyroid cancer. In three patients, medullary thyroid cancer was diagnosed via screening. In two of these patients, the calcitonin value normalized after thyroidectomy. One patient died of metastases from medullary thyroid cancer at the age of 20 years (median duration of follow-up, 10 years). Eight of the 18 patients had pheochromocytomas. All of our patients had neuromas and bumpy lips, and all but one had a marfanoid habitus. A large proportion of the patients had intestinal abnormalities (75%), thickened corneal nerves (69%), skeletal abnormalities (87%), and delayed puberty (43%).

Conclusions.—
The course of medullary thyroid cancer in MEN IIb is not always as aggressive as is generally thought. Periodic examination of relatives who are at risk may lead to early diagnosis and curative treatment. Intestinal abnormalities, skeletal abnormalities, and delayed puberty are commonly found in association with MEN IIb.

(Arch Intern Med. 1992;152:1250-1252)



Author Affiliations

From the Foundation for the Detection of Hereditary Tumour, Utrecht, the Netherlands (Drs Vasen and van der Feltz); Department of Internal Medicine, University of Heidelberg (Germany) (Dr Raue); Department of Endocrinology, University Hospital, Maastricht, the Netherlands (Dr Nieuwenhuyzen Kruseman); Department of Endocrinology, University Hospital, Utrecht (Drs Koppeschaar and Lips); Department of Endocrinology, University Hospital, Nijmegen, the Netherlands (Dr Pieters); Department of Internal Medicine, University of Tubingen (Germany) (Dr Seif); and Department of Pediatrics, University of Tubingen (Dr Blum).


Footnotes

Accepted for publication November 16, 1991.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET
Kasprzak et al.
J. Med. Genet. 2001;38:784-787.
FULL TEXT  

Constipation as the Presenting Symptom in De Novo Multiple Endocrine Neoplasia Type 2B
de Krijger et al.
Pediatrics 1998;102:405-407.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.